Table 1.
Univariate analyses | Multivariate analysis | |||||||
---|---|---|---|---|---|---|---|---|
Characteristics |
Patients (n) |
Patients (%) |
Median survival (months) |
5-Year survival (%) |
P | HR | 95% CI | P |
Age | ||||||||
≤ 20 years | 7 | 7 | NR | 57 | 0.960 | |||
21-60 years | 55 | 51 | NR | 64 | ||||
> 60 years | 46 | 43 | NR | 60 | ||||
Gender | ||||||||
Male | 47 | 44 | NR | 74 | 0.054 | |||
Female | 61 | 56 | 127 | 53 | ||||
Patient nationality | ||||||||
Norwegian | 73 | 68 | NR | 73 | < 0.001 | 1.000 | ||
Russian | 35 | 32 | 22 | 38 | 2.777 | 1.457-5.292 | 0.002 | |
Histological entity | ||||||||
Pleomorphic sarcoma | 29 | 27 | 54 | 50 | 0.127 | |||
Leiomyosarcoma | 34 | 32 | 68 | 53 | ||||
Liposarcoma | 13 | 12 | NR | 92 | ||||
Fibrosarcoma | 8 | 7 | NR | 88 | ||||
Angiosarcoma | 5 | 5 | NR | 60 | ||||
Rhabdomyosarcoma | 6 | 6 | NR | 67 | ||||
MPNST | 5 | 5 | NR | 80 | ||||
Synovial sarcoma | 6 | 6 | 59 | 80 | ||||
Sarcoma NOS | 2 | 2 | NR | 100 | ||||
Tumor localization | ||||||||
Extremities | 46 | 43 | NR | 66 | 0.735 | |||
Trunk | 21 | 19 | NR | 60 | ||||
Retroperitoneum | 7 | 7 | NR | 71 | ||||
Head/Neck | 4 | 4 | NR | 75 | ||||
Visceral | 30 | 28 | 63 | 53 | ||||
Tumor size | ||||||||
≤ 5 cm | 40 | 37 | NR | 75 | 0.262 | |||
5-10 cm | 46 | 43 | NR | 53 | ||||
> 10 cm | 20 | 18 | NR | 60 | ||||
Missing | 2 | 2 | ||||||
Malignancy grade | 0.015* | |||||||
1 | 32 | 30 | NR | 90 | < 0.001 | 1.000 | ||
2 | 36 | 33 | NR | 61 | 3.808 | 1.084-13.380 | 0.037 | |
3 | 40 | 37 | 32 | 39 | 5.937 | 1.721-20.481 | 0.005 | |
Tumor depth | ||||||||
Superficial | 12 | 11 | ** | ** | 0.009 | ** | ** | ** |
Deep | 96 | 89 | 57 | |||||
Metastasis at diagnosis | ||||||||
No | 97 | 90 | 218 | 66 | < 0.001 | 1.000 | ||
Yes | 11 | 10 | 8 | 27 | 4.689 | 2.004-10.972 | < 0.001 | |
Chemotherapy | ||||||||
No | 79 | 73 | NR | 65 | 0.234 | |||
Yes | 29 | 27 | 120 | 55 | ||||
Radiotherapy | ||||||||
No | 87 | 81 | NR | 63 | 0.375 | |||
Yes | 21 | 19 | NR | 57 |
Abbreviations: NR, not reached; MPNST, malignant peripheral nerve sheath tumor; NOS, not otherwise specified; *, overall significance as a prognostic factor; **all cases were censored.